Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease

Neuroscience Letters

Volumn 438, Issue 3, 2008, Pages 335-339

  Seripa, Davide ^a   Franceschi, Marilisa ^a   D'Onofrio, Grazia ^a   Panza, Francesco ^b   Cascavilla, Leandro ^a   Paris, Francesco ^a   Placentino, Giuliana ^a   Matera, Maria Giovanna ^a   Solfrizzi, Vincenzo ^b   Pilotto, Alberto ^a  

^a Gerontology Geriatrics Research Laboratory   (Italy)

^b Center for Aging Brain   (Italy)

Author keywords

5 Hydroxytriptamine (5HT); 5 Hydroxytriptamine transporter (5HTT); 5 Hydroxytriptamine transporter gene linked polymorphic region (5HTTLPR); Alzheimer's disease (AD); Polymorphism C; Questionable dementia (QD); Solute carrier family 6 (neurotransmitter transporter, serotonin) member 4 (SLC6A4)

Indexed keywords

SEROTONIN TRANSPORTER;

AGED; ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERIATRIC HOSPITAL; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STATISTICS, NONPARAMETRIC; TANDEM REPEAT SEQUENCES;

EID: 44349166816     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.04.076     Document Type: Article

References (40)

1. Alisky J.M. Neurotransmitter depletion may be a cause of dementia pathology rather than an effect. Med. Hypotheses 67 (2006) 556-560
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), Washington American Psychiatric Association
3. Ban Y., Watanabe T., Miyazaki A., Nakano Y., Tobe T., Idei T., Iguchi T., Ban Y., and Katagiri T. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis 195 (2007) 153-159
4. Buhot M.C., Martin S., and Segu L. Role of serotonin in memory impairment. Ann. Med. 32 (2000) 210-221
5. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
6. Cavalli-Sforza L.L. The human genome diversity project: past, present and future. Nat. Rev. Genet. 6 (2005) 333-340
7. Cervilla J.A., Rivera M., Molina E., Torres-Gonzalez F., Bellon J.A., Moreno B., de Dios Luna J., Lorente J.A., de Diego-Otero Y., King M., Nazareth I., Gutierrez B., and PREDICT Study Core Group. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-Gene Study. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 141 (2006) 912-917
8. Court J.A., and Perry E.K. Neurotransmitter abnormalities in vascular dementia. Int. Psychogeriatr. 15 (2003) 81-87
9. D'Ath P., Katona P., Mullan E., Evans S., and Katona C. Screening, detection and management of depression in elderly primary care attenders. I. The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam. Pract. 11 (1994) 260-266
10. Folstein M., Folstein S., and McHugh P.R. Minimental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
11. Gelernter J., Cubells J.F., Kidd J.R., Pakstis A.J., and Kidd K.K. Population studies of polymorphisms of the serotonin transporter protein gene. Am. J. Med. Genet. 88 (1999) 61-66
12. Gelernter J., and Freimer M. PstI RFLP at the SERT locus. Hum. Mol. Genet. 3 (1994) 383
13. Gerdes L.U., Klausen I.B., Sihm I., and Færgeman O. Apoliporpotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet. Epidemiol. 9 (1992) 155-167
14. Gonda X., Rihmer Z., Juhasz G., Zsombok T., and Bagdy G. High anxiety and migraine are associated with the s allele of the 5HTTLPR gene polymorphism. Psychiatr. Res. 149 (2007) 261-266
15. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., and Symon L. Cerebral blood flow in dementia. Arch. Neurol. 32 (1975) 632-637
16. Hasselbalch S.G., Madsen K., Svarer C., Pinborg L.H., Holm S., Paulson O.B., Waldemar G., and Knudsen G.M. Reduced 5-HT(2A) receptor binding in patients with mild cognitive impairment. Neurobiol. Aging (2007) 10.1016/j.neurobiolaging.2007.04.011
17. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., and Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66 (1996) 2621-2624
18. Hu M., Retz W., Baader M., Pesold B., Adler G., Henn F.A., Rosler M., and Thome J. Promoter polymorphism of the 5-HT transporter and Alzheimer's disease. Neurosci. Lett. 294 (2000) 63-65
19. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatr. 140 (1982) 566-572
20. Katz S., and Akpom C.A. A measure of primary sociobiological functions. Int. J. Health Serv. 6 (1976) 493-507
21. Kunugi H., Ueki A., Otsuka M., Isse K., Hirasawa H., Kato N., Nabika T., Kobayashi S., and Nanko S. Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association. Am. J. Med. Genet. 96 (2000) 307-309
22. Lawton M.P., and Brody E.M. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
23. Lesch K.P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., and Riederer P. Organization of the human serotonin transporter gene. J. Neural Transm. Gen. Sect. 95 (1994) 157-162
24. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
25. Li T., Holmes C., Sham P.C., Vallada H., Birkett J., Kirov G., Lesch K.P., Powell J., Lovestone S., and Collier D. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 8 (1997) 683-686
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
27. Meira-Lima I., Shavitt R.G., Miguita K., Ikenaga E., Miguel E.C., and Vallada H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav. 3 (2004) 75-79
28. Morris J.C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 43 (1993) 2412-2414
29. Mossner R., Schmitt A., Syagailo Y., Gerlach M., Riederer P., and Lesch K.P. The serotonin transporter in Alzheimer's and Parkinson's disease. J. Neural Transm. Suppl. 60 (2000) 345-350
30. Oliveira J.R., Gallindo R.M., Maia L.G., Brito-Marques P.R., Otto P.A., Passos-Bueno M.R., Morais Jr. M.A., and Zatz M. The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease. Mol. Psychiatr. 3 (1998) 438-441
31. Oliveira J.R., Shimokomaki C.M., Brito-Marques P.R., Gallindo R.M., Okuma M., Maia L.G., Otto P.A., Passos-Bueno M.R., and Zatz M. The association of the short variant of the 5-HTTPLR polymorphism and the apoE epsilon 4 allele does not increase the risk for late onset Alzheimer's disease. Mol. Psychiatr. 4 (1999) 19-20
32. Olsson C.A., Byrnes G.B., Anney R.J., Collins V., Hemphill S.A., Williamson R., and Patton G.C. COMT Val(158)Met and 5HTTLPR functional loci interact to predict persistence of anxiety across adolescence: results from the Victorian Adolescent Health Cohort Study. Genes Brain Behav. 6 (2007) 647-652
33. Panza F., D'Introno A., Colacicco A.M., Capurso C., Del Parigi A., Caselli R.J., Pilotto A., Argentieri G., Scapicchio P.L., Scafato E., Capurso A., and Solfrizzi V. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatr. 13 (2005) 633-644
34. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23 (1975) 433-441
35. Reisberg B., Ferris S.H., de Leon M.J., and Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatr. 139 (1982) 1136-1139
36. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.-M., Brun A., Hofman A., Moody D.M., O'Brien M.D., Yamaguchi T., Grafman J., Drayer B.P., Bennett D.A., Fisher M., Ogata J., Kokmen E., Bermejo F., Wolf P.A., Gorelick P.B., Bick K.L., Pajeau A.K., Bell M.A., DeCarli C., Culebras A., Korczyn A.D., Bogousslavsky J., Hartmann A., and Scheinberg P. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
37. L.Z. Rubenstein, L.V. Rubenstein, Comprehensive geriatric assessment of older patients with gastrointestinal disorders, in A. Pilotto, P. Malfertheiner, P.R. Holt (Eds.), Aging and the Gastrointestinal Tract, Interdiscipl. Top Gerontol, Basel, Karger, 2003 (32) 12-27.
38. Seripa D., Signori E., Gravina C., Matera M.G., Rinaldi M., and Fazio V.M. Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn. Mol. Pathol. 15 (2006) 180-185
39. The R Project for Statistical Computing. Available at URL http://www.r-project.org/ (last access 06/12/2007).
40. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., and Leirer V.O. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17 (1982-1983) 37-49